Iceland vs Southern Europe: Proportion of the target population who received
Iceland
98.0%
in 2024
Southern Europe
87.0%
in 2024
Iceland rank
17th
Southern Europe rank
14th
Proportion of the target population who received over time
- Iceland
- Southern Europe
How they compare
Iceland currently reports 98.0% against 87.0% in Southern Europe, a difference of 11.0%.
That makes Iceland's figure about 1.1 times Southern Europe's.
The two have swapped places 2 times across 22 shared years of data; in 2003 it was Iceland ahead.
Iceland ranks 17th and Southern Europe ranks 14th of 193 countries.
Across the 3 decades both report, Iceland averaged higher in 2 and Southern Europe in 1.
Head to head by decade
| Decade | Iceland | Southern Europe | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 92.3% | 50.3% | 42.0% | Iceland |
| 2010s | 93.9% | 79.5% | 14.4% | Iceland |
| 2020s | 74.0% | 87.4% | 13.4% | Southern Europe |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received, Iceland or Southern Europe?
- Iceland, at 98.0% against 87.0% in Southern Europe as of 2024.
- What is the difference in proportion of the target population who received between Iceland and Southern Europe?
- 11.0%, with Iceland ahead.
- How many years of comparable data are there for Iceland and Southern Europe?
- 22 years are reported by both, from 2003 to 2024.
- How do Iceland and Southern Europe rank globally for proportion of the target population who received?
- Iceland ranks 17th and Southern Europe ranks 14th of 193 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.